Malé, Maldives – Health Protection Agency (HPA) has revealed that 69,802 individuals of the eligible population for Covid-19 vaccination have received their second jab till now.
According to the statistics released by HPA, until yesterday 288,903 people had gotten their first dose.
The second dose of Covishield vaccine, developed by Oxford-AstraZeneca and manufactured by Serum Institute of India (SII), is administered 8 weeks after the first dose was administered.
While two Covid-19 vaccines are being administered currently in the Maldives for first dose vaccinations, Sinopharm and Pfizer, HPA has informed the public that the second dose will be of the same vaccine as they had received first.
Covishield first dose receivers will get Covishield as the second dose, and Sinopharm Covid-19 vaccine first receivers will get the Sinopharm Covid-19 vaccine second jab.
Maldives launched the Covid-19 Dhifaau campaign to vaccinate the entire eligible population on February 1, 2021.
The country administered 200,000 doses of Covishield which was received as donation from India for first dose administration. 12,000 doses of Covishield have been received through the WHO COVAX facility. Maldives also received 5,886 doses of Pfizer pledged by the COVAX facility. China donated 200,000 doses of Sinopharm vaccine to the Maldives.
Maldives placed an order for additional 300,000 doses of Covishield to be used for the second dose vaccinations.
Meanwhile, the government has signed an agreement with Astrazeneca Singapore Pte Ltd to buy 700,000 doses of the Covid-19 vaccine yet to arrive in the country.
